Research graph
References from 2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors. Local targets link to admitted publications; unresolved targets remain external evidence.
Bat-derivedinfluenza-like viruses H17N10 and H18N11
10.1016/j.tim.2014.01.010 · 2014 · External reference
New World bats harbor diverse influenza a viruses
10.1371/journal.ppat.1003657 · 2013 · External reference
10.1080/03079457.2013.823145
10.1080/03079457.2013.823145 · External reference
Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus
10.1016/j.vetimm.2017.08.001 · 2017 · External reference
47M birds dead in flu outbreak: Egg-laying hens hit hardest, followed by turkeys
2015 · External reference
Analysis of optimal timing of tourism demand recovery policies from natural disaster using the contingent behavior method
10.1016/j.tourman.2017.07.019 · 2018 · External reference
Avian influenza in the UK: knowledge, risk perception and risk reduction strategies
10.1108/00070700810858673 · 2013 · External reference
10.1016/j.antiviral.2013.03.014
10.1016/j.antiviral.2013.03.014 · External reference
10.1007/s11030-012-9384-z
10.1007/s11030-012-9384-z · External reference
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series
10.1021/bi0205449 · 2003 · External reference
10.4155/fmc.14.30
10.4155/fmc.14.30 · External reference
Influenza drug resistance
10.1055/s-0031-1283281 · 2011 · External reference
Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors
10.1007/s10822-011-9425-1 · 2011 · External reference
Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA
10.1016/j.bmc.2007.11.053 · 2008 · External reference
A Quantitative-Structure-Activity-Relationship (QSAR) model for the reaction rate constants of organic compounds during the ozonation process at different temperatures
10.1016/j.cej.2018.07.122 · 2018 · External reference
Quantitative structure-activity relationship between antioxidant capacity of phenolic compounds and the plasmonic properties of silver nanoparticles
10.1016/j.talanta.2018.06.080 · 2018 · External reference
10.1021/ci049820b
10.1021/ci049820b · External reference
QSAR and molecular mechanism analysis of N-substituted oseltamivir derivatives as potent avian influenza H5N1 neuraminidase inhibitors
10.1016/j.chemolab.2015.07.005 · 2015 · External reference
In vitro Antiviral Effects and 3D QSAR Study of Resveratrol Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase
10.1111/cbdd.12425 · 2015 · External reference
In vitro anti-influenza virus effect of total flavonoid from Trollius ledebouri Reichb
10.1177/0300060517750284 · 2018 · External reference
Design, synthesis and evaluation of chalcones as H1N1 Neuraminidase inhibitors
10.1007/s00044-017-2124-2 · 2018 · External reference
Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors
10.1016/j.bmcl.2013.04.033 · 2013 · External reference
QSAR study of H1N1 neuraminidase inhibitors from influenza a virus
2014 · External reference
Determination of structural requirements of influenza neuraminidase type A inhibitors and binding interaction analysis with the active site of A/H1N1 by 3D-QSAR CoMFA and CoMSIA modeling
10.1039/c1md00050k · 2011 · External reference
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus
10.1016/j.bbrc.2010.09.020 · 2010 · External reference
10.1021/ci800041k
10.1021/ci800041k · External reference
Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR)
10.1002/jcc.20776 · 2008 · External reference
Neuraminidase pharmacophore model derived from diverse classes of inhibitors
10.1016/j.bmcl.2006.09.055 · 2007 · External reference
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR
10.1007/s10822-006-9080-0 · 2006 · External reference
ChemDraw ultra 10.0
2006 · External reference
Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs
10.2147/dddt.s149973 · 2018 · External reference
10.1007/s00894-012-1667-x
10.1007/s00894-012-1667-x · External reference
2D-QSAR and 3D-QSAR analyses for EGFR inhibitors
10.1155/2017/4649191 · 2017 · External reference
Predicting network of drug-enzyme interaction based on machine learning method
10.1016/j.bbapap.2013.07.008 · 2014 · External reference
Best-first minimax search
10.1016/0004-3702(95)00096-8 · 1996 · External reference
Predicting toxic action mechanisms of phenols using AdaBoost Learner
10.1016/j.chemolab.2008.11.003 · 2009 · External reference
Predicting protein structural class with AdaBoost Learner
2006 · External reference
Application of machine learning approaches for protein-protein interactions prediction
10.2174/1573406413666170522150940 · 2017 · External reference
Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors
10.1111/cbdd.12917 · 2017 · External reference
Recent advances in fragment-based QSAR and multi-dimensional QSAR methods
10.3390/ijms11103846 · 2010 · External reference
Be aware of error measures. Further studies on validation of predictive QSAR models
10.1016/j.chemolab.2016.01.008 · 2016 · External reference
HQSAR and topomer CoMFA for predicting melanocortin-4 receptor binding affinities of trans-4-(4-chlorophenyl) pyrrolidine-3-carboxamides
10.1016/j.chemolab.2015.04.017 · 2015 · External reference
10.1128/jvi.01426-12
10.1128/jvi.01426-12 · External reference
10.1128/jvi.00180-16
10.1128/jvi.00180-16 · External reference
10.1002/jcc.540140907
10.1002/jcc.540140907 · External reference
Using support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors
10.1002/minf.201500107 · 2016 · External reference
Semiempirical topological index: A novel molecular descriptor for quantitative structure–retention relationship studies
2003 · External reference
Topomer-CoMFA-based predictive modelling on 2,3-diaryl-substituted-1,3-thiazolidin-4-ones as non-nucleoside reverse transcriptase inhibitors
10.1007/s00044-014-1105-y · 2015 · External reference
Design some New Type-I c-met Inhibitors based on Molecular Docking and Topomer CoMFA Research
10.1002/minf.201300118 · 2014 · External reference
QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators
10.1016/j.jmgm.2014.07.006 · 2014 · External reference
Topomer CoMFA and virtual screening studies of azaindole class renin inhibitors
10.2174/1386207317666140107094708 · 2014 · External reference
Beware of q(2)!
10.1016/s1093-3263(01)00123-1 · 2002 · External reference
10.1007/s00894-010-0847-9
10.1007/s00894-010-0847-9 · External reference
Microwave Assistant one Pot Synthesis, Crystal Structure, Antifungal Activities and 3D-QSAR of Novel 1,2,4-Triazolo[4,3-a]pyridines
10.1111/cbdd.12323 · 2014 · External reference
10.1128/jvi.00180-16
10.1128/jvi.00180-16 · External reference
10.1128/jvi.01426-12
10.1128/jvi.01426-12 · External reference
Studies on neuraminidase inhibition
10.1002/qua.25592 · 2018 · External reference
Unresolved reference
2016 · External reference
10.3201/eid2105.142020
10.3201/eid2105.142020 · External reference
Active principle from Moringa oleifera Lam leaves effective against two leukemias and a hepatocarcinoma
2010 · External reference
Immunomodulatory properties of quercetin-3-O-alpha-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus
10.1186/s12906-018-2246-1 · 2018 · External reference
In vitro anti-influenza virus effect of total flavonoid from Trollius ledebouri Reichb
10.1177/0300060517750284 · 2018 · External reference
Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones
10.1007/s00436-011-2763-z · 2012 · External reference
